Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas-Reference-Cited by-同舟云学术

Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas

Published:2010-02-02 Issue:S4 Volume:116 Page:1126-1133
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Palanca-Wessels M. Corinna A.,Press Oliver W.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin.,2008

2. Pilot studies of radioimmunotherapy of B cell lymphoma and leukemia using I-131-Lym1 monoclonal antibody;DeNardo;Antibody Immunoconjugates Radiopharmaceuticals.,1988

3. Maximum-tolerated dose, toxicity, and efficacy of I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma;DeNardo;J Clin Oncol.,1998

4. Radioimmunotherapy with iodine I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience;Kaminski;Blood.,2000

5. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma;Kaminski;J Clin Oncol.,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles;Scientific Reports;2016-01-07

2. Targeting FcRn for the modulation of antibody dynamics;Molecular Immunology;2015-10

3. Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission;Leukemia & Lymphoma;2015-08-28

4. Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET;Journal of Nuclear Medicine;2014-05-27

5. Advances in the treatment of hematologic malignancies using immunoconjugates;Blood;2014-04-10